XML 27 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation
9 Months Ended
Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
STOCK-BASED COMPENSATION
 
Our 2014 Long Term Stock Incentive Plan provides for the issuance of stock-based incentives in various forms to our employees and non-employee Directors.  At September 30, 2017, outstanding stock-based incentives were in the form of long-term stock awards, stock options, restricted stock units, phantom stock awards and stock appreciation rights.    

Pre-tax compensation expense for these stock-based incentives were as follows, in millions: 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2017
 
2016
 
2017
 
2016
Long-term stock awards
$
6

 
$
5

 
$
19

 
$
17

Stock options

 
1

 
2

 
2

Restricted stock units

 

 
1

 

Phantom stock awards and stock appreciation rights
2

 
4

 
7

 
6

Total
$
8

 
$
10

 
$
29

 
$
25


    
Long-Term Stock Awards.  Long-term stock awards are granted to our key employees and non-employee Directors and do not cause net share dilution inasmuch as we continue the practice of repurchasing and retiring an equal number of shares in the open market.  We granted 819,000 shares of long-term stock awards in the nine-month period ended September 30, 2017.
H. STOCK-BASED COMPENSATION (Continued)

Our long-term stock award activity was as follows, shares in millions: 
 
Nine Months Ended September 30,
 
2017
 
2016
Unvested stock award shares at January 1
4

 
5

Weighted average grant date fair value
$
20

 
$
17

 
 
 
 
Stock award shares granted
1

 
1

Weighted average grant date fair value
$
34

 
$
26

 
 
 
 
Stock award shares vested
2

 
2

Weighted average grant date fair value
$
18

 
$
16

 
 
 
 
Stock award shares forfeited

 

Weighted average grant date fair value
$
24

 
$
20

 
 
 
 
Unvested stock award shares at September 30
3

 
4

Weighted average grant date fair value
$
24

 
$
20



At September 30, 2017 and 2016, there was $50 million and $49 million, respectively, of total unrecognized compensation expense related to unvested stock awards; such awards had a weighted average remaining vesting period of three years at both September 30, 2017 and 2016.     
    
The total market value (at the vesting date) of stock award shares which vested during the nine-month periods ended September 30, 2017 and 2016 was $45 million and $43 million, respectively.
 
Stock Options.  Stock options are granted to certain key employees. The exercise price equals the market price of our common stock at the grant date. These options generally become exercisable (vest ratably) over five years beginning on the first anniversary from the date of grant and expire no later than 10 years after the grant date.
 
We granted 397,350 shares of stock options in the nine-month period ended September 30, 2017 with a grant date weighted-average exercise price of approximately $34 per share. In the nine-month period ended September 30, 2017, no stock option shares were forfeited (including options that expired unexercised).



















H. STOCK-BASED COMPENSATION (Continued)

Our stock option activity was as follows, shares in millions: 
 
 
Nine Months Ended September 30,
 
 
2017
 
 
2016
Option shares outstanding, January 1
 
7

 
 
12

Weighted average exercise price
$
15

 
$
17

 
 
 
 
 
 
Option shares granted
 

 
 

Weighted average exercise price
$
34

 
$
26

 
 
 
 
 
 
Option shares exercised
 
1

 
 
5

Aggregate intrinsic value on date of exercise (A) 
$
36 million

 
$
64 million

Weighted average exercise price
$
15

 
$
21

 
 
 
 
 
 
Option shares forfeited
 

 
 

Weighted average exercise price
$

 
$

 
 
 
 
 
 
Option shares outstanding, September 30
 
6

 
 
7

Weighted average exercise price
$
16

 
$
15

Weighted average remaining option term (in years)
 
4

 
 
4

 
 
 
 
 
 
Option shares vested and expected to vest, September 30
 
6

 
 
7

Weighted average exercise price
$
16

 
$
15

Aggregate intrinsic value (A) 
$
132 million

 
$
137 million

Weighted average remaining option term (in years)
 
4

 
 
4

 
 
 
 
 
 
Option shares exercisable (vested), September 30
 
4

 
 
6

Weighted average exercise price
$
13

 
$
13

Aggregate intrinsic value (A) 
$
115 million

 
$
117 million

Weighted average remaining option term (in years)
 
3

 
 
3

 
 
(A)
Aggregate intrinsic value is calculated using our stock price at each respective date, less the exercise price (grant date price), multiplied by the number of shares.

At September 30, 2017 and 2016, there was $8 million and $7 million, respectively, of unrecognized compensation expense (using the Black-Scholes option pricing model at the grant date) related to unvested stock options; such options had a weighted average remaining vesting period of three years at both September 30, 2017 and 2016.











H. STOCK-BASED COMPENSATION (Concluded)

The weighted average grant date fair value of option shares granted and the assumptions used to estimate those values using a Black-Scholes option pricing model were as follows: 
 
Nine Months Ended September 30,
 
2017
 
2016
Weighted average grant date fair value
$
9.68

 
$
6.43

Risk-free interest rate
2.16
%
 
1.41
%
Dividend yield
1.19
%
 
1.49
%
Volatility factor
30.00
%
 
29.00
%
Expected option life
6 years

 
6 years



Restricted Stock Units. In March 2017, our Organization and Compensation Committee ("Compensation Committee") of the Board of Directors approved a Long Term Incentive Program ("LTIP Program"), replacing our previous Long Term Cash Incentive Plan. Under the LTIP Program, we granted restricted stock units to certain senior executives. These restricted stock units will vest and share awards will be issued at no cost to the employees, subject to our achievement of specified return on invested capital performance goals over a three-year period that have been established by the Compensation Committee for the performance period and the employee's continued employment through the share award date. Restricted stock units are granted at a target number; based on our performance, the number of restricted stock units that vest can be adjusted downward to zero and upward to a maximum of 200%. We granted 124,780 restricted stock units in the nine-month period ended September 30, 2017, with a grant date fair value of approximately $34 per share. No restricted stock units were forfeited in the nine-month period ended September 30, 2017.